Kaya Holdings (KAYS) Income from Continuing Operations (2011 - 2025)

Kaya Holdings (KAYS) recorded quarterly Income from Continuing Operations of 8591465.0 in Q3 2025, down 229.26% quarter-over-quarter from 2609336.0 in Q2 2025, and down 258.32% on a YoY basis from 5426571.86 in Q3 2024.

Kaya Holdings (KAYS) Income from Continuing Operations (2011 - 2025) Analysis & Trends

Kaya Holdings' Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 8591465.0 for Q3 2025.

  • In Q3 2025, Income from Continuing Operations fell 258.32% year-over-year to 8591465.0; the TTM figure through Sep 2025 stood at 11912295.0 (down 301.4% YoY), while the FY2024 annual figure was 2060111.0, down 239.52% from the prior year.
  • Income from Continuing Operations was 8591465.0 for Q3 2025 at Kaya Holdings, down from 2609336.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9096960.0 in Q2 2021 to a low of 8591465.0 in Q3 2025.
  • Historically, Income from Continuing Operations has averaged 365746.89 across 5 years, with a median of 34933.0 in 2023.
  • Biggest YoY gain for Income from Continuing Operations was 1505.88% in 2024; the steepest drop was 3094.09% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 2650418.0 in 2021, then plunged by 32.0% to 1802212.0 in 2022, then sank by 96.67% to 60080.0 in 2023, then surged by 1505.88% to 964814.0 in 2024, then slumped by 990.48% to 8591465.0 in 2025.
  • The last three Income from Continuing Operations figures came in at 8591465.0 (Q3 2025), 2609336.0 (Q2 2025), and 1676308.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Kaya Holdings - - 5,370.00 -8.59 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 -8.59 Mn
Jun 30, 2025 -2.61 Mn
Mar 31, 2025 -1.68 Mn
Dec 31, 2024 964,814.00
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 415,873.00
Mar 31, 2024 -1.05 Mn
Dec 31, 2023 60,080.00
Sep 30, 2023 2.10 Mn
Jun 30, 2023 -714,156.00
Mar 31, 2023 34,933.00
Dec 31, 2022 1.80 Mn
Sep 30, 2022 -7.44 Mn
Jun 30, 2022 3.07 Mn
Mar 31, 2022 -1.10 Mn
Dec 31, 2021 2.65 Mn
Sep 30, 2021 3.93 Mn
Jun 30, 2021 9.10 Mn
Mar 31, 2021 -5.51 Mn
Dec 31, 2020 3.26 Mn